Christoph Dauth

Title: Christoph Dauth: Innovator in Ergoline Derivatives

Introduction

Christoph Dauth is a notable inventor based in Radebeul, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the production of ergoline derivatives. His innovative work has led to the development of a patented process that enhances the production of valuable alkaloids.

Latest Patents

Christoph Dauth holds a patent for a process for the fermentation production of ergoline derivatives. This patent involves creating a submerged culture under aerobic conditions by inoculating an aqueous medium that contains a carbon source, an organic or inorganic nitrogen source, and nutrient salts. The inoculum consists of spores obtained from a strain of Claviceps purpurea, which is deposited under number IMET PA 130. After the cultivation is complete, the formed alkaloids are extracted from the culture, and if necessary, they are further processed into pharmaceutically acceptable acid addition salts. This innovative approach has the potential to significantly impact the pharmaceutical industry.

Career Highlights

Christoph Dauth is associated with Veb Arzneimittelwerk Dresden, where he has been instrumental in advancing research and development in the field of pharmaceuticals. His expertise in fermentation processes and alkaloid production has positioned him as a key figure in his organization.

Collaborations

Throughout his career, Christoph has collaborated with notable colleagues, including Eva Borowski and Klaus Braun. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Christoph Dauth's contributions to the field of ergoline derivatives exemplify the importance of innovation in pharmaceuticals. His patented process not only enhances the production of valuable compounds but also showcases the potential for advancements in medical applications.